<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1111">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 18, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04331366</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000381</org_study_id>
    <nct_id>NCT04331366</nct_id>
  </id_info>
  <brief_title>Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19</brief_title>
  <acronym>GO2 PEEP</acronym>
  <official_title>GO2 PEEP Study: The Use of a Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the safety, feasibility and efficacy of a&#xD;
      bidirectional oxygenation Positive End Expiratory Pressure (PEEP) mouthpiece in coronavirus&#xD;
      disease 2019 (COVID-19) patients requiring supplemental oxygen by non-rebreather mask.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe cases of COVID-19 often mimic the typical course of Adult Respiratory Distress&#xD;
      Syndrome (ARDS) and its predictable sequelae. These patients often require intubation and&#xD;
      ventilator support in order to sustain adequate oxygenation. Once a COVID-19 patient is&#xD;
      intubated, Positive End Expiratory Pressure (PEEP) is a mainstay of treatment and is used in&#xD;
      order to improve lung function, treat underlying atelectasis, improve oxygenation, and&#xD;
      improve survival. In fact, early clinical data as well as reports from front line physicians&#xD;
      treating COVID-19 suggest that PEEP has been the most effective treatment modality. In many&#xD;
      cases, PEEP has resulted in improved oxygenation and improved survival.&#xD;
&#xD;
      PEEP decreases the propensity for the alveoli to collapse by increasing the air pressure in&#xD;
      the lungs. This residual pressure in the lungs at the end of exhalation decreases shunting&#xD;
      and allows for more complete gas exchange and improved oxygenation. In patients, PEEP is one&#xD;
      of the safest ways to increase partial pressure of oxygen (PaO2) and is used on almost all&#xD;
      modern ventilator settings.&#xD;
&#xD;
      The GO2 PEEP MOUTHPIECE is a simple, comfortable, and straightforward mouthpiece with a&#xD;
      bidirectional valve that effectively delivers PEEP with every breath. Early application of&#xD;
      the GO2 PEEP MOUTHPIECE in non-intubated COVID-19 patients may improve outcomes and save&#xD;
      lives. Furthermore, this device may allow for less strain on limited resources, especially&#xD;
      ventilators. This PEEP mouthpiece could be employed under an oxygen non-rebreather mask to&#xD;
      improve oxygenation and avoid intubation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 8, 2020</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen Saturation by Pulse Oximetry</measure>
    <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
    <description>Pulse oximetry is a way to assess whether or not a patient needs help breathing. Oxygen saturation levels for healthy individuals are 95% and above.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
    <description>The number of breaths per minute was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
    <description>Heart rate, in beats per minute, was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
    <description>Systolic and diastolic blood pressure was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Count of Participants With Subjective Work of Breathing</measure>
    <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
    <description>Participants were observed for stridor, grunting, nasal flaring, or accessory muscle use. The presence of any of these indicates that increased effort is required for breathing.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Treatment with GO2 PEEP MOUTHPIECE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GO2 PEEP MOUTHPIECE</intervention_name>
    <description>The GO2 PEEP MOUTHPIECE has a bidirectional valve that delivers PEEP with each breath. Participants will be provided a G02 PEEP MOUTHPIECE to use underneath the oxygen face mask and will be instructed to breathe slowly and deeply through the mouthpiece for 15 minutes total. Metrics for primary and secondary endpoints will be recorded immediately prior to use and then at 5, 10 and 15 minutes of use and then 15 minutes after cessation of use.</description>
    <arm_group_label>Treatment with GO2 PEEP MOUTHPIECE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 positive&#xD;
&#xD;
          -  Oxygen saturation &lt;92%&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  Receiving oxygen by non-rebreather mask&#xD;
&#xD;
          -  Not currently requiring intubation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable or unwilling to provide informed consent&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Rapidly decompensating status requiring urgent or emergent higher level of care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory St. Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 31, 2020</study_first_submitted>
  <study_first_submitted_qc>March 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <results_first_submitted>February 5, 2021</results_first_submitted>
  <results_first_submitted_qc>February 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 10, 2021</results_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Jeffrey Miller</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Bidirectional oxygenation</keyword>
  <keyword>Pulmonary compromise</keyword>
  <keyword>Supplemental oxygen</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04331366/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled at Emory Saint Joseph's Hospital and Emory University Hospital in Atlanta, Georgia. Enrollment began on April 8, 2020 and all follow up was complete by August 31, 2020.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>GO2 PEEP MOUTHPIECE</title>
          <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GO2 PEEP MOUTHPIECE</title>
          <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.71" spread="21.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Oxygen Saturation by Pulse Oximetry</title>
        <description>Pulse oximetry is a way to assess whether or not a patient needs help breathing. Oxygen saturation levels for healthy individuals are 95% and above.</description>
        <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GO2 PEEP MOUTHPIECE</title>
            <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Saturation by Pulse Oximetry</title>
          <description>Pulse oximetry is a way to assess whether or not a patient needs help breathing. Oxygen saturation levels for healthy individuals are 95% and above.</description>
          <units>percentage of oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" spread="1.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" spread="1.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate</title>
        <description>The number of breaths per minute was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
        <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GO2 PEEP MOUTHPIECE</title>
            <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate</title>
          <description>The number of breaths per minute was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
          <units>breaths per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="1.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" spread="0.707"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>Heart rate, in beats per minute, was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
        <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GO2 PEEP MOUTHPIECE</title>
            <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Heart rate, in beats per minute, was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" spread="17.678"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" spread="17.678"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.5" spread="20.506"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="16.263"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="14.849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure</title>
        <description>Systolic and diastolic blood pressure was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
        <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GO2 PEEP MOUTHPIECE</title>
            <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure</title>
          <description>Systolic and diastolic blood pressure was assessed before treatment, during treatment, and 15 minutes after the end of treatment.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152.5" spread="31.820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" spread="7.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 5 Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155" spread="21.213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 5 Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5" spread="10.607"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10 Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150" spread="21.213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10 Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15 Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145" spread="21.213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15 Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.5" spread="3.536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment) Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152.5" spread="24.749"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment) Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" spread="7.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Count of Participants With Subjective Work of Breathing</title>
        <description>Participants were observed for stridor, grunting, nasal flaring, or accessory muscle use. The presence of any of these indicates that increased effort is required for breathing.</description>
        <time_frame>Baseline, Minutes 5, 10, 15, 30 (15 minutes after treatment ends)</time_frame>
        <population>Data on subjective work of breathing were not collected at the Baseline and Minute 30 time points.</population>
        <group_list>
          <group group_id="O1">
            <title>GO2 PEEP MOUTHPIECE</title>
            <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
          </group>
        </group_list>
        <measure>
          <title>Count of Participants With Subjective Work of Breathing</title>
          <description>Participants were observed for stridor, grunting, nasal flaring, or accessory muscle use. The presence of any of these indicates that increased effort is required for breathing.</description>
          <population>Data on subjective work of breathing were not collected at the Baseline and Minute 30 time points.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
            <class>
              <title>Minute 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minute 30 (15 minutes post-treatment)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were assessed for adverse events on the day of the intervention beginning just prior to treatment with the mouthpiece through 15 minutes after the cessation of PEEP therapy, for a total of up to 30 minutes.</time_frame>
      <desc>Participants were assessed for the following adverse events:&#xD;
Decreased oxygen saturation&#xD;
Increased respiratory rate&#xD;
Increased heart rate&#xD;
Low blood pressure&#xD;
Increased work of breathing&#xD;
Worsening arterial blood gases (if available)&#xD;
Inability to tolerate the mouthpiece</desc>
      <group_list>
        <group group_id="E1">
          <title>GO2 PEEP MOUTHPIECE</title>
          <description>Participants receiving treatment with the GO2 PEEP MOUTHPIECE.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Decrease in oxygen saturation after cessation of PEEP therapy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffery Miller, MD</name_or_title>
      <organization>Emory University</organization>
      <phone>404-778-7200</phone>
      <email>jeffrey.miller@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

